Extracellular matrix remodeling in heart failure: a role for de novo angiotensin II generation.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Circulation

• Publication date

  1997-12-02

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.CIR.96.11.4065PMID 9403633
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Increased contractility of isolated lung parenchyma in an animal model of pulmonary fibrosis induced by bleomycin.

  2015cited by this paper
• The Molecular and Cellular Biology of Wound Repair

  2012cited by this paper
• Immunohistochemical study of angiotensin-converting enzyme in human tissues using monoclonal antibodies

  2004cited by this paper
• Fibrosis of atria and great vessels in response to angiotensin II or aldosterone infusion.

  1997cited by this paper
• Extracellular Fibrillar Structure of Latent TGFβ Binding Protein-1: Role in TGFβ-dependent Endothelial-Mesenchymal Transformation during Endocardial Cushion Tissue Formation in Mouse Embryonic Heart

  1997cited by this paper
• Fibrous tissue and angiotensin II.

  1997cited by this paper
• Angiotensin II Induces Apoptosis of Adult Ventricular MyocytesIn Vitro

  1997cited by this paper
• Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats.

  1997cited by this paper
• Myofibroblasts and local angiotensin II in rat cardiac tissue repair.

  1997cited by this paper
• Angiotensin II receptor blockade and myocardial fibrosis of the infarcted rat heart.

  1997cited by this paper
• Fibrosis, a common pathway to organ failure: angiotensin II and tissue repair.

  1997cited by this paper
• Angiotensin II induces apoptosis of adult ventricular myocytes in vitro.

  1997cited by this paper
• Fibrosis, a common pathway to organ failure: angiotensin II and tissue repair.

  1997cited by this paper
• Angiotensin II stimulated expression of transforming growth factor-beta1 in cardiac fibroblasts and myofibroblasts.

  1997cited by this paper
• Cultured myofibroblasts generate angiotensin peptides de novo.

  1997cited by this paper
• Regression of hypertrophy after myocardial infarction is produced by the chronic blockade of angiotensin type 1 receptor in rats.

  1996cited by this paper
• Glomerulosclerosis: the final pathway is clarified, but can we deal with the triggers?

  1996cited by this paper
• TCV-116 inhibits renal interstitial and glomerular injury in glomerulosclerotic rats.

  1996cited by this paper
• Valvular interstitial cells express angiotensinogen and cathepsin D, and generate angiotensin peptides.

  1996cited by this paper
• Wound healing following myocardial infarction in the rat: role for bradykinin and prostaglandins.

  1996cited by this paper
• Cells expressing angiotensin II receptors in fibrous tissue of rat heart.

  1996cited by this paper
• Regional changes in angiotensin II receptor density after experimental myocardial infarction.

  1996cited by this paper
• Effect of ramipril and losartan on collagen expression in right and left heart after myocardial infarction

  1996cited by this paper
• In situ production of angiotensin II by fibrosed rat pericardium.

  1996cited by this paper
• New activity of spironolactone. Inhibition of angiogenesis in vitro and in vivo.

  1996cited by this paper
• Delayed treatment with enalapril halts tubulointerstitial fibrosis in rats with obstructive nephropathy.

  1996cited by this paper
• Angiotensin converting enzyme and myofibroblasts during tissue repair in the rat heart.

  1996cited by this paper
• Angiotensin II-induced myocardial fibrosis in rats: role of nitric oxide, prostaglandins and bradykinin.

  1996cited by this paper
• Mediators of perivascular inflammation in the left ventricle of renovascular hypertensive rats.

  1996cited by this paper
• Captopril prevents vascular and fibrotic changes but not cardiac hypertrophy in aortic-banded rats.

  1996cited by this paper
• The effect of ACE inhibitors on the expression of matrix genes and the role of p53 and p21 (WAF1) in experimental renal fibrosis.

  1996cited by this paper
• Angiotensin-converting enzyme and wound healing in diverse tissues of the rat.

  1996cited by this paper
• Renin is expressed in rat macrophage/monocyte cells.

  1996cited by this paper
• Effects of angiotensin II and aldosterone on collagen gene expression and protein turnover in cardiac fibroblasts

  1996cited by this paper
• The cicatrix: a case of woven intrigue.

  1996cited by this paper
• Angiotensin II type 2 receptor mediates programmed cell death.

  1996cited by this paper
• Right ventricular diastolic dysfunction in heart failure.

  1996cited by this paper
• Involvement of angiotensin II in glomerulosclerosis of stroke-prone spontaneously hypertensive rats.

  1996cited by this paper
• Respective role of humoral factors and blood pressure in cardiac remodeling of DOCA hypertensive rats.

  1996cited by this paper
• Genes up-regulated in hypertrophied ventricle.

  1995cited by this paper
• Internephron heterogeneity of growth factors and sclerosis--modulation of platelet-derived growth factor by angiotensin II.

  1995cited by this paper
• Molecular signalling mechanisms controlling growth and function of cardiac fibroblasts.

  1995cited by this paper
• Role of angiotensin II in the expression and regulation of transforming growth factor-beta in obstructive nephropathy.

  1995cited by this paper
• Regulation of collagen degradation in the rat myocardium after infarction.

  1995cited by this paper
• Angiotensin II stimulates the autocrine production of transforming growth factor-beta 1 in adult rat cardiac fibroblasts.

  1995cited by this paper
• Effect of angiotensin II blockade on the fibroproliferative response to phenylephrine in the rat heart.

  1995cited by this paper
• Connective tissue: a metabolic entity? .

  1995cited by this paper
• Collagen remodeling after myocardial infarction in the rat heart.

  1995cited by this paper
• Cellular distribution of angiotensin-converting enzyme after myocardial infarction.

  1995cited by this paper
• Effect of enalapril on ventricular remodeling and function during healing after anterior myocardial infarction in the dog.

  1995cited by this paper
• Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar.

  1995cited by this paper
• Expression of endothelins 1 and 3 in the rat kidney.

  1995cited by this paper
• Wound healing in cardiovascular disease

  1995cited by this paper
• Endothelin production in cultured mesangial cells of spontaneously hypertensive rats.

  1995cited by this paper
• Increased angiotensin converting enzyme activity in left ventricular aneurysm of patients after myocardial infarction.

  1995cited by this paper
• Endothelin Production in Cultured Mesangial Cells of Spontaneously Hypertensive Rats

  1995cited by this paper
• Regulation, chamber localization, and subtype distribution of angiotensin II receptors in human hearts.

  1995cited by this paper
• Angiotensin II type I receptor antagonist inhibits the gene expression of transforming growth factor-beta 1 and extracellular matrix in cardiac and vascular tissues of hypertensive rats.

  1995cited by this paper
• Angiotensin II stimulates the autocrine production of transforming growth factor-β1 in adult rat cardiac fibroblasts

  1995cited by this paper
• The Role of Nitric Oxide in Inflammation

  1995cited by this paper
• Identification and activation of autocrine renin-angiotensin system in adult ventricular myocytes.

  1995cited by this paper
• Angiotensin-II-induced increase in transcoronary protein clearance: role of hypertension vs. nitric oxide or cyclo-oxygenase products.

  1995cited by this paper
• Molecular mechanisms and therapeutic strategies related to nitric oxide

  1995cited by this paper
• Exercise gas exchange in heart disease

  1995cited by this paper
• Cell death in health and disease: the biology and regulation of apoptosis.

  1995cited by this paper
• Determinants of cardiac fibrosis in experimental hypermineralocorticoid states.

  1995cited by this paper
• Angiotensin II induces cardiac phenotypic modulation and remodeling in vivo in rats.

  1995cited by this paper
• Temporal differences in fibroblast proliferation and phenotype expression in response to chronic administration of angiotensin II or aldosterone.

  1995cited by this paper
• Role of angiotensin II in the expression and regulation of transforming growth factor-β in obstructive nephropathy

  1995cited by this paper
• Activation of angiotensin-converting enzyme expression in infarct zone following myocardial infarction.

  1995cited by this paper
• Angiotensin converting enzyme and kininase-II-like activities in cultured valvular interstitial cells of the rat heart.

  1995cited by this paper
• Inhibition by angiotensin II type 1 receptor antagonist of cardiac phenotypic modulation after myocardial infarction.

  1995cited by this paper
• Myofibroblasts and the progression of experimental glomerulonephritis.

  1995cited by this paper
• Myocardial fibrosis and stiffness with hypertrophy and heart failure in the spontaneously hypertensive rat.

  1995cited by this paper
• Angiotensin II-induced cardiac fibrosis in the rat is increased by chronic inhibition of nitric oxide synthase.

  1995cited by this paper
• Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction.

  1995cited by this paper
• Reactive Oxygen Intermediates Mediate Angiotensin II-induced c-Jun•c-Fos Heterodimer DNA Binding Activity and Proliferative Hypertrophic Responses in Myogenic Cells (*)

  1995cited by this paper
• The role of nitric oxide in inflammation.

  1995cited by this paper
• Chronic inhibition of nitric oxide synthesis causes coronary microvascular remodeling in rats.

  1995cited by this paper
• Bradykinin receptor and tissue ACE binding in myocardial fibrosis: response to chronic angiotensin II or aldosterone administration in rats.

  1995cited by this paper
• Inhibition of angiotensin-converting enzyme and attenuation of myocardial fibrosis by lisinopril in rats receiving angiotensin II.

  1995cited by this paper
• Unravelling the mysteries of collagen and cicatrix after myocardial infarction.

  1995cited by this paper
• Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction.

  1995cited by this paper
• Effect of captopril and enalapril on left ventricular geometry, function and collagen during healing after anterior and inferior myocardial infarction in a dog model.

  1995cited by this paper
• Angiotensin receptor regulates cardiac hypertrophy and transforming growth factor-beta 1 expression.

  1994cited by this paper
• Regional differences in LV collagen accumulation and mature cross-linking after myocardial infarction in rats.

  1994cited by this paper
• Angiotensin II induced expression of transcription factors precedes increase in transforming growth factor-beta 1 mRNA in neonatal cardiac fibroblasts.

  1994cited by this paper
• 3. Vascular aldosterone. Biosynthesis and a link to angiotensin II-induced hypertrophy of vascular smooth muscle cells

  1994cited by this paper
• Alterations in cardiac gene expression during the transition from stable hypertrophy to heart failure. Marked upregulation of genes encoding extracellular matrix components.

  1994cited by this paper
• Transforming growth factor beta 1 and extracellular matrix gene expression in isoprenaline induced cardiac hypertrophy: effects of inhibition of the renin-angiotensin system.

  1994cited by this paper
• Cardiac renin and angiotensins. Uptake from plasma versus in situ synthesis.

  1994cited by this paper
• Structural alterations in heart valves during left ventricular pressure overload in the rat.

  1994cited by this paper
• Markedly different effects on ventricular remodeling result in a decrease in inducibility of ventricular arrhythmias.

  1994cited by this paper
• Mineralocorticoids, hypertension, and cardiac fibrosis.

  1994cited by this paper
• Structural basis of end-stage failure in ischemic cardiomyopathy in humans.

  1994cited by this paper
• Prophylaxis of experimental bone marrow transplant nephropathy.

  1994cited by this paper
• Fibrogenesis and type I collagen gene regulation.

  1994cited by this paper
• Survival after myocardial infarction in the rat. Role of tissue angiotensin-converting enzyme inhibition.

  1994cited by this paper
• Renin is not synthesized by cardiac and extrarenal vascular tissues. A review of experimental evidence.

  1994cited by this paper
• Synthesis of corticosterone in the vascular wall.

  1994cited by this paper

• Harnessing mRNA technology for ischemic heart disease: a review of regenerative and protective therapies

  2025cites this paper
• A Molecular Perspective on the Intricate Interplay Among Exosomes, Bioenergetic Metabolism, and the Pathogenesis of Diabetic Cardiomyopathy

  2025cites this paper
• The Role of Chemokines and Small Leucine-Rich Proteoglycans in Cardiac Remodeling in Immunosuppressant-Treated Male Rats

  2025cites this paper
• Imperatorin's Effect on Myocardial Infarction Based on Network Pharmacology and Molecular Docking

  2025cites this paper
• Exploring the Molecular Underpinnings of Skin Regeneration and Wound Healing: The Role of Renin Angiotensin

  2024cites this paper
• Angiotensin II—Real-Life Use and Literature Review

  2024cites this paper
• A modular platform to generate functional sympathetic neuron-innervated heart assembloids

  2024cites this paper
• Myocardial infarction with a preserved ejection fraction—the impaired function of the cardio-renal baroreflex

  2023cites this paper
• Diastolic function in chronic kidney disease

  2023cites this paper
• The Possible Influence of Vitamin D Levels on the Development of Atrial Fibrillation—An Update

  2023cites this paper
• Cardiac-specific BACH1 ablation attenuates pathological cardiac hypertrophy by inhibiting the Ang II type 1 receptor expression and the Ca2+/CaMKII pathway.

  2023cites this paper
• Insulin‐Like Growth Factor 1 Receptor Deficiency Alleviates Angiotensin II–Induced Cardiac Fibrosis Through the Protein Kinase B/Extracellular Signal‐Regulated Kinase/Nuclear Factor‐κB Pathway

  2023cites this paper
• Overview of the RGD-Based PET Agents Use in Patients With Cardiovascular Diseases: A Systematic Review

  2022cites this paper
• Myocardial effects of angiotensin II compared to norepinephrine in an animal model of septic shock

  2022cites this paper
• Ca2+/calmodulin‐dependent protein kinase II and protein kinase G oxidation contributes to impaired sarcomeric proteins in hypertrophy model

  2022cites this paper
• Target Sestrin2 to Rescue the Damaged Organ: Mechanistic Insight into Its Function

  2021cites this paper
• Novel factors that activate and deactivate cardiac fibroblasts: A new perspective for treatment of cardiac fibrosis

  2021cites this paper
• Beneficial Extracardiac Effects of Cardiovascular Medications

  2021cites this paper
• A novel method for sensor-based quantification of single/multicellular force dynamics and stiffening in 3D matrices

  2021cites this paper
• Transcriptomic Analysis of Mouse Brain After Traumatic Brain Injury Reveals That the Angiotensin Receptor Blocker Candesartan Acts Through Novel Pathways

  2021cites this paper
• Association Between Serum Matrix Metalloproteinase-12/Angiotensin Ii Profile And Left Ventricular Hypertrophy In Patients With Heart Failure

  2020cites this paper
• Vascular smooth muscle remodeling in health and disease.

  2020cites this paper
• Draft 1 Vascular smooth muscle remodeling in health and disease 2

  2020cites this paper
• Lipid Peroxidation in Atherosclerotic Cardiovascular Diseases

  2020cites this paper
• Doxorubicin induces cardiotoxicity in a pluripotent stem cell model of aggressive B cell lymphoma cancer patients

  2020cites this paper
• Signalling pathways linking cysteine cathepsins to adverse cardiac remodelling.

  2020cites this paper
• Losing Regulation of the Extracellular Matrix is Strongly Predictive of Unfavorable Prognostic Outcome after Acute Myocardial Infarction

  2020cites this paper
• A three‐tiered integrative analysis of transcriptional data reveals the shared pathways related to heart failure from different aetiologies

  2020cites this paper
• A novel method for sensor-based quantification of single/multi-cellular traction dynamics and remodeling in 3D matrices

  2020cites this paper
• Heart Failure due to Left Ventricular Systolic Dysfunction

  2020cites this paper
• Sex related differences in the pathogenesis of organ fibrosis.

  2020cites this paper
• Beta-Blockers Versus ACE Inhibitors in Heart Failure with Reduced Ejection Fraction: Which Should Be Utilized First?

  2019cites this paper
• Oxidative Stress and Heart Failure

  2019cites this paper
• The immunomodulatory role of interleukin-35 in fibrotic diseases

  2019cites this paper
• Proteomics and N‐glycoproteomics analysis of an extracellular matrix‐based scaffold‐human treated dentin matrix

  2019cites this paper
• Evaluation of myocardial protective effects of enalapril maleate against experimental supraventricular tachyarrhythmia in dogs by measuring cardiac troponin I levels

  2019cites this paper
• Association Between Timp-3/Angiotensin II, Profile and Cardiac Remodeling in Patients with Essential Hypertension and Heart Failure with Mid-Range Ejection Fraction

  2019cites this paper
• Recovery of left ventricular twist and left ventricular untwist rate in patients with ST-segment elevation acute myocardial infarction

  2019influential citation
• The complex dynamics of myocardial interstitial fibrosis in heart failure. Focus on collagen cross-linking.

  2019cites this paper
• Doxorubicin-Induced Cardiomyopathy in Children.

  2019cites this paper
• Fibrotic Signaling in Cardiomyopathies

  2018cites this paper
• Programmed necrosis in cardiomyocytes: mitochondria, death receptors and beyond

  2018cites this paper
• Angiotensin II confers resistance to apoptosis in cardiac myofibroblasts through the AT1/ERK1/2/RSK1 pathway

  2018cites this paper
• Reduction of cardiac TGFβ-mediated profibrotic events by inhibition of Hsp90 with engineered protein.

  2018cites this paper
• Targeted Treatment of Ischemic and Fibrotic Complications of Myocardial Infarction Using a Dual-Delivery Microgel Therapeutic.

  2018cites this paper
• MYOCARDIAL REACTION TO ENERGY DRINKS IN A GUINE A PIG: STRUCTURAL CHANGES

  2017cites this paper
• Investigating the anti-apoptotic effect of sesame oil and honey in a novel nanostructure form for treatment of heart failure

  2017cites this paper
• The effect of angiotensin II on blood pressure in patients with circulatory shock: a structured review of the literature

  2017cites this paper
• In vitro model to study the effects of matrix stiffening on Ca2+ handling and myofilament function in isolated adult rat cardiomyocytes

  2017cites this paper
• Inhibitory effects of oxymatrine on TGF-β1-induced proliferation and abnormal differentiation in rat cardiac fibroblasts via the p38MAPK and ERK1/2 signaling pathways

  2017cites this paper
• Detrimental role of lysyl oxidase in cardiac remodeling.

  2017cites this paper
• Plasma renin activity in patients with heart failure and reduced ejection fraction on optimal medical therapy

  2017cites this paper
• Heart Failure with Normal Left Ventricular Ejection Fraction (HFNEF)

  2017cites this paper
• Chapter 5 Galectin-3 and Post-Myocardial Infarction Cardiac Remodeling

  2017cites this paper
• Individual evaluation of cardiac marker expression and self-beating during cardiac differentiation of P19CL6 cells on different culture substrates.

  2017cites this paper
• Angiotensin II receptor blockers suppress the release of stromal cell-derived factor-1α from infarcted myocardium in patients with acute myocardial infarction.

  2017cites this paper
• Immunity, Inflammation, and Oxidative Stress in Heart Failure: Emerging Molecular Targets

  2017cites this paper
• Fibroblasts in an endocardial fibroelastosis disease model mainly originate from mesenchymal derivatives of epicardium

  2017cites this paper
• The Role of Endoglin in Myocardial Fibrosis.

  2017cites this paper
• Long-term left ventricular remodelling after revascularisation for ST-segment elevation myocardial infarction as assessed by cardiac magnetic resonance imaging

  2017cites this paper
• Nanofiber composites in cardiac tissue engineering

  2017cites this paper
• Adverse outcomes following percutaneous transcatheter interventions

  2017cites this paper
• Clinical Experience With IV Angiotensin II Administration: A Systematic Review of Safety

  2017influential citation
• Understanding the role of MasR in vascular pathology

  2016cites this paper
• Ultrasound-Mediated S100A6 Gene Therapy Ameliorates Myocardial Ischemia/Reperfusion (I/R) Injury

  2016cites this paper
• Tripartite motif-containing 55 identified as functional candidate for spontaneous cardiac hypertrophy in the rat locus cardiac mass 22

  2016cites this paper
• Melatonin attenuates angiotensin II-induced cardiomyocyte hypertrophy through the CyPA/CD147 signaling pathway

  2016cites this paper
• Study of interaction between Si(O,C) nanowires and the biological system

  2016cites this paper
• Dynamics and prognostic role of galectin-3 in patients with advanced heart failure, during left ventricular assist device support and following heart transplantation

  2016cites this paper
• Urinary Proteomics Pilot Study for Biomarker Discovery and Diagnosis in Heart Failure with Reduced Ejection Fraction

  2016cites this paper
• Antioxidative and antisenescent effects of cardiac rehabilitation in heart failure patients

  2016cites this paper
• Fibulin-2 is Essential for Angiotensin II-Induced Myocardial Fibrosis Mediated by Transforming Growth Factor (TGF)-β

  2016cites this paper
• Urine proteome analysis in heart failure with reduced ejection fraction complicated by chronic kidney disease: feasibility, and clinical and pathogenetic correlates

  2016cites this paper
• failurein rats with experimental congestive heart Cardiac and renal effects of omapatrilat, a vasopeptidase

  2016cites this paper
• ffects of Loop Diuretics on yocardial Fibrosis and Collagen ype I Turnover in Chronic Heart Failure

  2016cites this paper
• May the fibrosis be with you: Is discoidin domain receptor 2 the receptor we have been looking for?

  2016cites this paper
• Carbon Nanohorns Promote Maturation of Neonatal Rat Ventricular Myocytes and Inhibit Proliferation of Cardiac Fibroblasts: a Promising Scaffold for Cardiac Tissue Engineering

  2016cites this paper
• Post Myocardial Infarction Remodelling

  2016cites this paper
• systolic heart failure? Does load-induced ventricular hypertrophy progress to

  2016cites this paper
• Use of angiotensin receptor – neprilysin inhibitors in heart failure: a paradigm shift

  2016cites this paper
• Protective Effect of Adansonia digitata against Isoproterenol-Induced Myocardial Injury in Rats

  2016cites this paper
• Genetic Variations in Renin-Angiotensin-Aldosterone System (RAAS) Genes Could Contribute to High Altitude Pulmonary Edema: Review

  2015cites this paper
• Single bolus versus split dose gadolinium administration in extra-cellular volume calculation at 3 Tesla

  2015cites this paper
• Cardiopulmonary reflex, cardiac cytokines, and nandrolone decanoate: response to resistance training in rats.

  2015cites this paper
• Exogenous Nkx2.5- or GATA-4-transfected rabbit bone marrow mesenchymal stem cells and myocardial cell co-culture on the treatment of myocardial infarction in rabbits

  2015cites this paper
• Biomarkers of the extracellular matrix and of collagen fragments.

  2015cites this paper
• Left ventricular mechanics in advanced heart failure patients

  2015cites this paper
• Diastolic heart failure

  2015cites this paper
• Mechanoregulation of cardiac myofibroblast differentiation: implications for cardiac fibrosis and therapy.

  2015cites this paper
• Galectin-3 and post-myocardial infarction cardiac remodeling.

  2015cites this paper
• Role of redoximiRs in fibrogenesis

  2015cites this paper
• GPCR signaling and cardiac function.

  2015cites this paper
• Ang (1–7) is a modulator of the vasoconstrictor actions of Ang I and Ang II

  2015cites this paper
• Pharmacological Inhibition of Focal Adhesion Kinase Attenuates Cardiac Fibrosis in Mice Cardiac Fibroblast and Post-Myocardial-Infarction Models

  2015cites this paper
• Cardiac-Restricted IGF-1Ea Overexpression Reduces the Early Accumulation of Inflammatory Myeloid Cells and Mediates Expression of Extracellular Matrix Remodelling Genes after Myocardial Infarction

  2015cites this paper
• Post Myocardial Infarction Remodelling (Review Article) Author

  2015cites this paper
• Diverse Cellular Origins of Cardiac Fibroblasts

  2015cites this paper
• Fibrosis and heart failure

  2014cites this paper
• Die Rolle der Ekto-5´-Nukleotidase (CD73) bei der Entzündungsreaktion nach Herzinfarkt in der Maus

  2014influential citation
• Long-term results of pulmonary vein antrum isolation in patients with atrial fibrillation: an analysis in regards to substrates and pulmonary vein reconnections.

  2014cites this paper